BACKGROUND AND PURPOSE: Knowledge about cytotoxic edema (CE) in intracerebral hemorrhage is still limited. We aimed to analyze its presence, temporal pattern, and prognostic meaning. METHODS: Twenty-one patients with primary intracerebral hemorrhage underwent magnetic resonance imaging at days 1, 3, and 7 after symptom onset. CE was identified using diffusion-weighted imaging. Hematoma and perihematomal edema volumes were measured on fluid-attenuated inversion recovery images. National Institutes of Health Stroke Scale score was assessed at admission and with each magnetic resonance imaging. Clinical outcome was assessed by modified Rankin scale at 90 days. RESULTS: CE appeared in half of the patients within the first 24 hours. The apparent diffusion coefficient values decreased until day 3 and were significantly reversed from days 3 through 7 (P<0.01). Patients with CE showed significantly faster perihematomal edema growth from day 0 to 1 (P=0.036) than those without. Larger 3-day perihematomal edema volume (P=0.02) and presence of CE on day 3 (P=0.07) were associated with poor clinical outcome. CONCLUSIONS: CE is associated with stroke severity, perihematomal edema volume, and poor outcome. It is considered to indicate ongoing neuronal injury and, thus, might emerge as new treatment target.
BACKGROUND AND PURPOSE: Knowledge about cytotoxic edema (CE) in intracerebral hemorrhage is still limited. We aimed to analyze its presence, temporal pattern, and prognostic meaning. METHODS: Twenty-one patients with primary intracerebral hemorrhage underwent magnetic resonance imaging at days 1, 3, and 7 after symptom onset. CE was identified using diffusion-weighted imaging. Hematoma and perihematomal edema volumes were measured on fluid-attenuated inversion recovery images. National Institutes of Health Stroke Scale score was assessed at admission and with each magnetic resonance imaging. Clinical outcome was assessed by modified Rankin scale at 90 days. RESULTS: CE appeared in half of the patients within the first 24 hours. The apparent diffusion coefficient values decreased until day 3 and were significantly reversed from days 3 through 7 (P<0.01). Patients with CE showed significantly faster perihematomal edema growth from day 0 to 1 (P=0.036) than those without. Larger 3-day perihematomal edema volume (P=0.02) and presence of CE on day 3 (P=0.07) were associated with poor clinical outcome. CONCLUSIONS: CE is associated with stroke severity, perihematomal edema volume, and poor outcome. It is considered to indicate ongoing neuronal injury and, thus, might emerge as new treatment target.
Authors: Rajat Dhar; Guido J Falcone; Yasheng Chen; Ali Hamzehloo; Elayna P Kirsch; Rommell B Noche; Kilian Roth; Julian Acosta; Andres Ruiz; Chia-Ling Phuah; Daniel Woo; Thomas M Gill; Kevin N Sheth; Jin-Moo Lee Journal: Stroke Date: 2019-12-06 Impact factor: 7.914
Authors: Hans Worthmann; Na Li; Jens Martens-Lobenhoffer; Meike Dirks; Ramona Schuppner; Ralf Lichtinghagen; Jan T Kielstein; Peter Raab; Heinrich Lanfermann; Stefanie M Bode-Böger; Karin Weissenborn Journal: J Neuroinflammation Date: 2017-12-13 Impact factor: 8.322
Authors: Rustam Al-Shahi Salman; Joseph Frantzias; Robert J Lee; Patrick D Lyden; Thomas W K Battey; Alison M Ayres; Joshua N Goldstein; Stephan A Mayer; Thorsten Steiner; Xia Wang; Hisatomi Arima; Hitoshi Hasegawa; Makoto Oishi; Daniel A Godoy; Luca Masotti; Dar Dowlatshahi; David Rodriguez-Luna; Carlos A Molina; Dong-Kyu Jang; Antonio Davalos; José Castillo; Xiaoying Yao; Jan Claassen; Bastian Volbers; Seiji Kazui; Yasushi Okada; Shigeru Fujimoto; Kazunori Toyoda; Qi Li; Jane Khoury; Pilar Delgado; José Álvarez Sabín; Mar Hernández-Guillamon; Luis Prats-Sánchez; Chunyan Cai; Mahesh P Kate; Rebecca McCourt; Chitra Venkatasubramanian; Michael N Diringer; Yukio Ikeda; Hans Worthmann; Wendy C Ziai; Christopher D d'Esterre; Richard I Aviv; Peter Raab; Yasuo Murai; Allyson R Zazulia; Kenneth S Butcher; Seyed Mohammad Seyedsaadat; James C Grotta; Joan Martí-Fàbregas; Joan Montaner; Joseph Broderick; Haruko Yamamoto; Dimitre Staykov; E Sander Connolly; Magdy Selim; Rogelio Leira; Byung Hoo Moon; Andrew M Demchuk; Mario Di Napoli; Yukihiko Fujii; Craig S Anderson; Jonathan Rosand Journal: Lancet Neurol Date: 2018-08-14 Impact factor: 44.182
Authors: Kathryn N Kearns; Natasha Ironside; Min S Park; Bradford B Worrall; Andrew M Southerland; Ching-Jen Chen; Dale Ding Journal: Neurocrit Care Date: 2021-08-02 Impact factor: 3.210